Yoko Hagino - Concepedia

Author

Yoko Hagino

Tokyo Institute of Psychiatry

Also Known As

Hagino, Yoko, Y HAGINO, Y Hagino, Y. Hagino, YOKO HAGINO, Yoko Hagino

Publications

Citations

H-Index

Concepts

All Affiliations

Tokyo Institute of Psychiatry Tokyo Metropolitan Institute of Medical Science Tohoku University Yokohama City University The University of Tokyo

About

Yoko Hagino is an author at Tokyo Institute of Psychiatry specializing in neuroscience, neuropharmacology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	14	492
2	Social Sciences	9	9	208
3	Neurology	4	4	97
4	Health Sciences	3	3	238
5	Anesthesia	1	1	11

Yoko Hagino

Publications

927

Citations

H-Index

Page 1

	Year	Citations
Regional Differences in Extracellular Dopamine and Serotonin Assessed by In Vivo Microdialysis in Mice Lacking Dopamine and/or Serotonin Transporters Haowei Shen, Yoko Hagino, Hideaki Kobayashi, Neuropsychopharmacology Health SciencesNeurophysiologyNeuroanatomyPhysiologyNeurotransmitter	2004	204
Effects of MDMA on Extracellular Dopamine and Serotonin Levels in Mice Lacking Dopamine and/or Serotonin Transporters Yoko Hagino, Yukio Takamatsu, Hideko Yamamoto, Current Neuropharmacology	2011	62
Effects of rapamycin on social interaction deficits and gene expression in mice exposed to valproic acid in utero Hiroko Kotajima‐Murakami, Toshiyuki Kobayashi, Hirofumi Kashii, Molecular Brain	2019	55
Brain hyperserotonemia causes autism-relevant social deficits in mice Miho Tanaka, Atsushi Sato, Shinya Kasai, Molecular Autism	2018	51
Essential Role of NMDA Receptor Channel ε4 Subunit (GluN2D) in the Effects of Phencyclidine, but Not Methamphetamine Yoko Hagino, Shinya Kasai, Wenhua Han, PLoS ONE	2010	47
Specific Roles of NMDA Receptor Subunits in Mental Disorders Hideko Yamamoto, Yoko Hagino, Shinya Kasai, Current Molecular Medicine NeuropsychologyPsychiatric DisordersNeurotransmitterNeuropsychiatrySocial Sciences	2015	47
Fluoxetine as a Potential Pharmacotherapy for Methamphetamine Dependence Yukio Takamatsu, Hideko Yamamoto, Yasukazu Ogai, Annals of the New York Academy of Sciences	2006	39
Involvement of the N-methyl-d-aspartate receptor GluN2D subunit in phencyclidine-induced motor impairment, gene expression, and increased Fos immunoreactivity Hideko Yamamoto, Etsuko Kamegaya, Wakako Sawada, Molecular Brain	2013	35
Loss of GluN2D subunit results in social recognition deficit, social stress, 5-HT2C receptor dysfunction, and anhedonia in mice Hideko Yamamoto, Etsuko Kamegaya, Yoko Hagino, Neuropharmacology Stress HormonePsychiatryBehavioral NeuroscienceSocial Recognition DeficitAffective Neuroscience	2016	35
Involvement of Cholinergic System in Hyperactivity in Dopamine-Deficient Mice Yoko Hagino, Shinya Kasai, Masayo Fujita, Neuropsychopharmacology Dopaminergic SystemsPsychiatryNeurophysiologyMedicineNeurotransmitter	2014	33

Page 1